Hopewell Therapeutics
Synthetic Lipid for Gene Therapy and Genome Editing.
Launch date
Employees
Market cap
-
Enterprise valuation
€91—136m (Dealroom.co estimates Jun 2023.)
Woburn Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $8.0m | Early VC | |
* | N/A | $7.1m | Early VC |
* | $25.0m | Seed | |
| Total Funding | €36.5m | ||